Nancie M Archin

12PUBLICATIONS
18CO-AUTHORS
Medical devicesInnate immunityGene and molecular therapyRegenerative medicine (incl. stem cells)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 11, 2025
BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cells.

Anne-Marie W Turner, Frances M Bashore, Shane D Falcinelli

|Dec 26, 2024
The persistent pool of HIV-1-infected cells is formed episodically during untreated infection.

Olivia D Council, Lynn Tyers, Matthew Moeser

|Sep 11, 2024
Integrator complex subunit 12 knockout overcomes a transcriptional block to HIV latency reversal.

Carley N Gray, Manickam Ashokkumar, Derek H Janssens

|Aug 13, 2024
Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoir.

Lijun Ling, Manse Kim, Andrew Soper

|Jun 03, 2024
Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets.

Samuel L M Raines, Shane D Falcinelli, Jackson J Peterson

|Feb 20, 2024
A novel high-throughput microwell outgrowth assay for HIV-infected cells.

Anthony D Fenton, Nancie Archin, Anne-Marie Turner

Pageof 2

Frequent Collaborators

4 joint publications

Ellen Van Gulck

3 joint publications

David M Margolis

2 joint publications

Edward P Browne

1 joint publications

Lijun Ling